Mean excitation energy determination for Monte Carlo simulations of boron carbide as degrader material for proton therapy.
Boron carbide
Energy degrader
Monte-Carlo simulations
Proton therapy
Journal
Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
30
04
2020
revised:
14
09
2020
accepted:
18
09
2020
pubmed:
3
11
2020
medline:
25
6
2021
entrez:
2
11
2020
Statut:
ppublish
Résumé
Boron carbide is a material proposed as an alternative to graphite for use as an energy degrader in proton therapy facilities, and is favoured due to its mechanical robustness and promise to give lower lateral scattering for a given energy loss. However, the mean excitation energy of boron carbide has not yet been directly measured. Here we present a simple method to determine the mean excitation energy by comparison with the relative stopping power in a water phantom, and from a comparison between experimental data and simulations we derive a value for it of 83.1 ± 2.8 eV suitable for use in Monte-Carlo simulation. This is consistent with the existing ICRU estimate (84.7 eV with 10-15% uncertainty) that is based on indirect Bragg additivity calculation, but it has a substantially smaller uncertainty. The method described can be readily applied to predict the ionisation loss of other boron carbide materials in which the atomic constituent ratio may vary, and allows this material to be reliably used as an alternative to graphite, diamond or beryllium.
Identifiants
pubmed: 33137622
pii: S1120-1797(20)30231-3
doi: 10.1016/j.ejmp.2020.09.017
pii:
doi:
Substances chimiques
Boron
N9E3X5056Q
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
111-118Informations de copyright
Copyright © 2020 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.